Preoperative and Postoperative Radiosurgery in Patients With Brain Metastases Undergoing Surgery
Key facts
- Who runs it
- Fundacion Miguel Servet
- Where
- Spain5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 30 Sept 2026
- Expected to end
- 31 Mar 2030
- Type of study
- Interventional, 2 groups
- Treatments tested
- SRS
- metastasectomy: surgical resection
- Record updated
- 18 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age ≥18 years
- Histologically confirmed solid tumor with one to four brain metastases
- At least one brain metastasis considered suitable for surgical resection and stereotactic radiosurgery
- Karnofsky Performance Status (KPS) ≥70
- Life expectancy ≥3 months
- Ability to undergo MRI examinations
- Written informed consent provided
Who cannot take part
- Prior radiotherapy to the index lesion
- Contraindication to surgery or stereotactic radiosurgery
- Brain metastases from small-cell lung cancer, germ cell tumors, lymphoma, or leukemia
- Leptomeningeal disease at baseline
- Any condition that, in the investigator's opinion, would interfere with study participation or evaluation
- Pregnancy or breastfeeding
This trial is currently available in Spain.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The PREOP-RAD study aims to evaluate the feasibility, safety, and efficacy of preoperative surgical resection (SRS) in patients with large brain metastases requiring surgical resection, taking into account potential differences based on sex/gender, compared to postoperative SRS, within the Spanish healthcare context.
Read full original descriptionShow less
More specifically, the study seeks to:
* Assess the clinical and radiological outcomes of the preoperative strategy in terms of local control, progression-free survival, and the occurrence of radionecrosis or neuromuscular dysfunction (nMD) compared to the postoperative strategy. * Study the histopathological profile of resected lesions before and after SRS, searching for personalized biomarkers of response and toxicity. * Identify patterns based on radiomic analysis and advanced imaging related to therapeutic response, recurrence, and complications.
PREOP-RAD is a prospective, randomized, multicenter study that will include patients diagnosed with symptomatic, single or multiple brain metastases ≥2 cm who are candidates for surgical resection. The procedure will consist of preoperative administration of SRS (1-5 fractions, depending on location and size), followed by surgery within a maximum of 10 days.
The intervention will be carried out in coordination with the Neurosurgery and Radiation Oncology Departments of each participating center, using a standardized workflow. The collection of surgical samples will allow for centralized histopathological studies. Furthermore, pre- and postoperative images will undergo radiomic analysis using artificial intelligence tools to explore similarities and correlate morphological and textural characteristics with clinical outcomes.
The 2 groups in the trial
- preoperative radiosurgeryTreatment being tested
preoperative radiosurgery (SRS) in patients with brain metastases who are candidates for surgery
Treatment: SRS and metastasectomy: surgical resection
- postoperative radiosurgeryOther group
standard treatment, consisting of surgical resection followed by irradiation of the tumor bed
Treatment: SRS and metastasectomy: surgical resection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Randomized Phase II/III Study Comparing Preoperative Radiosurgery Versus Postoperative Radiosurgery in Patients With Brain Metastases Eligible for Surgery: Correlation With Histopathological Factors and Radiomic Analysis.
- Record updated
- 18 November 2026